{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:11:02Z","timestamp":1793315462793,"version":"4.5.0"},"reference-count":192,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS060123"],"award-info":[{"award-number":["R01 NS060123"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013301","name":"Parkinson's Foundation","doi-asserted-by":"publisher","award":["PF-RC-936279"],"award-info":[{"award-number":["PF-RC-936279"]}],"id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-023721"],"award-info":[{"award-number":["MJFF-023721"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuron loss and the accumulation of misfolded \u03b1-synuclein, yet the underlying mechanisms remain incompletely understood. Over the past two decades, genetic discoveries have highlighted the convergence of multiple familial PD genes on the autophagy-lysosome pathway (ALP), a key cellular system responsible for the degradation and recycling of intracellular components. Recent studies have further revealed that components of the ALP not only mediate the clearance of \u03b1-synuclein aggregates but also, under certain pathological conditions, contribute to their propagation via lysosomal exocytosis or secretory autophagy. The precise functions of autophagy are highly context-dependent, with neuronal and glial cells exhibiting distinct ALP dynamics that shift with development, stress, and aging. In this review, we summarize current knowledge on the physiological regulation of autophagy in the brain and critically examine its involvement in PD pathogenesis, incorporating mechanistic insights from familial models and emerging evidence from sporadic PD. We also explore translational implications, focusing on efforts to identify ALP-related biomarkers in cerebrospinal fluid and urine, and on the therapeutic potential of modulating ALP activity. Although the causality between ALP dysfunction and PD remains elusive, mounting evidence supports its contribution to disease progression, particularly through impaired lysosomal homeostasis and disrupted intracellular trafficking. Future research should aim to define cell type-specific ALP alterations, clarify the bidirectional interactions between \u03b1-synuclein and autophagic machinery, and develop in vivo tools to monitor autophagy activity and secretory signatures. A deeper understanding of these processes will be crucial for refining PD models, discovering robust fluid biomarkers, and designing targeted therapies capable of modifying disease trajectory.<\/jats:p>","DOI":"10.1186\/s40035-026-00555-3","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T02:28:21Z","timestamp":1778120901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The emerging role and therapeutic targeting of autophagy-lysosome pathway in the pathogenesis of Parkinson\u2019s disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Takahiro","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanem","family":"Isik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitika","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"5","key":"555_CR1","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1056\/NEJMra2401857","volume":"391","author":"CM Tanner","year":"2024","unstructured":"Tanner CM, Ostrem JL. Parkinson\u2019s disease. N Engl J Med. 2024;391(5):442\u201352.","journal-title":"N Engl J Med"},{"issue":"2","key":"555_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Nalls MA, Singleton AB. The genetic architecture of Parkinson\u2019s disease. Lancet Neurol. 2020;19(2):170\u20138.","journal-title":"Lancet Neurol"},{"issue":"11","key":"555_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41580-024-00757-5","volume":"25","author":"RA Nixon","year":"2024","unstructured":"Nixon RA, Rubinsztein DC. Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases. Nat Rev Mol Cell Biol. 2024;25(11):926\u201346.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"555_CR4","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/ng.3955","volume":"49","author":"D Chang","year":"2017","unstructured":"Chang D, Nalls MA, Hallgrimsdottir IB, Hunkapiller J, van der Brug M, Cai F, et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci. Nat Genet. 2017;49(10):1511\u20136.","journal-title":"Nat Genet"},{"issue":"6","key":"555_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41576-022-00562-w","volume":"24","author":"H Yamamoto","year":"2023","unstructured":"Yamamoto H, Zhang S, Mizushima N. Autophagy genes in biology and disease. Nat Rev Genet. 2023;24(6):382\u2013400.","journal-title":"Nat Rev Genet"},{"issue":"25","key":"555_CR6","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1056\/NEJMoa1915722","volume":"384","author":"JJ Collier","year":"2021","unstructured":"Collier JJ, Guissart C, Olahova M, Sasorith S, Piron-Prunier F, Suomi F, et al. Developmental consequences of defective ATG7-mediated autophagy in humans. N Engl J Med. 2021;384(25):2406\u201317.","journal-title":"N Engl J Med"},{"key":"555_CR7","doi-asserted-by":"publisher","first-page":"e12245","DOI":"10.7554\/eLife.12245","volume":"5","author":"M Kim","year":"2016","unstructured":"Kim M, Sandford E, Gatica D, Qiu Y, Liu X, Zheng Y, et al. Mutation in ATG5 reduces autophagy and leads to ataxia with developmental delay. Elife. 2016;5:e12245.","journal-title":"Elife"},{"issue":"35","key":"555_CR8","doi-asserted-by":"publisher","first-page":"23542","DOI":"10.1074\/jbc.M801992200","volume":"283","author":"T Vogiatzi","year":"2008","unstructured":"Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem. 2008;283(35):23542\u201356.","journal-title":"J Biol Chem"},{"issue":"27","key":"555_CR9","doi-asserted-by":"publisher","first-page":"25009","DOI":"10.1074\/jbc.M300227200","volume":"278","author":"JL Webb","year":"2003","unstructured":"Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC. Alpha-synuclein is degraded by both autophagy and the proteasome. J Biol Chem. 2003;278(27):25009\u201313.","journal-title":"J Biol Chem"},{"issue":"1","key":"555_CR10","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","volume":"11","author":"I Choi","year":"2020","unstructured":"Choi I, Zhang Y, Seegobin SP, Pruvost M, Wang Q, Purtell K, et al. Microglia clear neuron-released alpha-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun. 2020;11(1):1386.","journal-title":"Nat Commun"},{"issue":"2","key":"555_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.108893","volume":"27","author":"T Abe","year":"2024","unstructured":"Abe T, Kuwahara T, Suenaga S, Sakurai M, Takatori S, Iwatsubo T. Lysosomal stress drives the release of pathogenic alpha-synuclein from macrophage lineage cells via the LRRK2-Rab10 pathway. iScience. 2024;27(2):108893.","journal-title":"iScience"},{"issue":"5","key":"555_CR12","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1080\/15548627.2021.1967615","volume":"18","author":"K Burbidge","year":"2022","unstructured":"Burbidge K, Rademacher DJ, Mattick J, Zack S, Grillini A, Bousset L, et al. LGALS3 (galectin 3) mediates an unconventional secretion of SNCA\/alpha-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons. Autophagy. 2022;18(5):1020\u201348.","journal-title":"Autophagy"},{"issue":"6","key":"555_CR13","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1083\/jcb.201003122","volume":"190","author":"AR Winslow","year":"2010","unstructured":"Winslow AR, Chen CW, Corrochano S, Acevedo-Arozena A, Gordon DE, Peden AA, et al. alpha-Synuclein impairs macroautophagy: implications for Parkinson\u2019s disease. J Cell Biol. 2010;190(6):1023\u201337.","journal-title":"J Cell Biol"},{"issue":"1","key":"555_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41422-024-01022-2","volume":"35","author":"Q Xu","year":"2025","unstructured":"Xu Q, Wang H, Yang R, Tao Y, Wang Z, Zhang S, et al. alpha-Synuclein amyloid fibril directly binds to LC3B and suppresses SQSTM1\/p62-mediated selective autophagy. Cell Res. 2025;35(1):72\u20135.","journal-title":"Cell Res"},{"issue":"6","key":"555_CR15","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.neuron.2022.01.017","volume":"110","author":"A Fleming","year":"2022","unstructured":"Fleming A, Bourdenx M, Fujimaki M, Karabiyik C, Krause GJ, Lopez A, et al. The different autophagy degradation pathways and neurodegeneration. Neuron. 2022;110(6):935\u201366.","journal-title":"Neuron"},{"issue":"7","key":"555_CR16","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1091\/mbc.e08-12-1248","volume":"20","author":"N Hosokawa","year":"2009","unstructured":"Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell. 2009;20(7):1981\u201391.","journal-title":"Mol Biol Cell"},{"issue":"12","key":"555_CR17","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.15252\/embj.201695189","volume":"36","author":"T Nishimura","year":"2017","unstructured":"Nishimura T, Tamura N, Kono N, Shimanaka Y, Arai H, Yamamoto H, et al. Autophagosome formation is initiated at phosphatidylinositol synthase-enriched ER subdomains. EMBO J. 2017;36(12):1719\u201335.","journal-title":"EMBO J"},{"issue":"2","key":"555_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.molcel.2014.05.021","volume":"55","author":"HC Dooley","year":"2014","unstructured":"Dooley HC, Razi M, Polson HE, Girardin SE, Wilson MI, Tooze SA. WIPI2 links LC3 conjugation with PI3P, autophagosome formation, and pathogen clearance by recruiting Atg12-5-16L1. Mol Cell. 2014;55(2):238\u201352.","journal-title":"Mol Cell"},{"issue":"16","key":"555_CR19","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1093\/hmg\/ddad096","volume":"32","author":"T Shimizu","year":"2023","unstructured":"Shimizu T, Tamura N, Nishimura T, Saito C, Yamamoto H, Mizushima N. Comprehensive analysis of autophagic functions of WIPI family proteins and their implications for the pathogenesis of beta-propeller associated neurodegeneration. Hum Mol Genet. 2023;32(16):2623\u201337.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"555_CR20","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1083\/jcb.201811139","volume":"218","author":"DP Valverde","year":"2019","unstructured":"Valverde DP, Yu S, Boggavarapu V, Kumar N, Lees JA, Walz T, et al. ATG2 transports lipids to promote autophagosome biogenesis. J Cell Biol. 2019;218(6):1787\u201398.","journal-title":"J Cell Biol"},{"issue":"Pt 9","key":"555_CR21","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1242\/jcs.00381","volume":"116","author":"N Mizushima","year":"2003","unstructured":"Mizushima N, Kuma A, Kobayashi Y, Yamamoto A, Matsubae M, Takao T, et al. Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. J Cell Sci. 2003;116(Pt 9):1679\u201388.","journal-title":"J Cell Sci"},{"issue":"6700","key":"555_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/26506","volume":"395","author":"N Mizushima","year":"1998","unstructured":"Mizushima N, Noda T, Yoshimori T, Tanaka Y, Ishii T, George MD, et al. A protein conjugation system essential for autophagy. Nature. 1998;395(6700):395\u20138.","journal-title":"Nature"},{"issue":"3","key":"555_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41580-022-00542-2","volume":"24","author":"JNS Vargas","year":"2023","unstructured":"Vargas JNS, Hamasaki M, Kawabata T, Youle RJ, Yoshimori T. The mechanisms and roles of selective autophagy in mammals. Nat Rev Mol Cell Biol. 2023;24(3):167\u201385.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"555_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41556-019-0450-y","volume":"22","author":"AM Leidal","year":"2020","unstructured":"Leidal AM, Huang HH, Marsh T, Solvik T, Zhang D, Ye J, et al. The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles. Nat Cell Biol. 2020;22(2):187\u201399.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"555_CR25","doi-asserted-by":"publisher","first-page":"e202110151","DOI":"10.1083\/jcb.202110151","volume":"221","author":"TA Solvik","year":"2022","unstructured":"Solvik TA, Nguyen TA, Tony Lin YH, Marsh T, Huang EJ, Wiita AP, et al. Secretory autophagy maintains proteostasis upon lysosome inhibition. J Cell Biol. 2022;221(6):e202110151.","journal-title":"J Cell Biol."},{"issue":"43","key":"555_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo1274","volume":"8","author":"J Durgan","year":"2022","unstructured":"Durgan J, Florey O. Many roads lead to CASM: diverse stimuli of noncanonical autophagy share a unifying molecular mechanism. Sci Adv. 2022;8(43):eabo1274.","journal-title":"Sci Adv"},{"issue":"17","key":"555_CR27","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1038\/emboj.2013.171","volume":"32","author":"I Maejima","year":"2013","unstructured":"Maejima I, Takahashi A, Omori H, Kimura T, Takabatake Y, Saitoh T, et al. Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. EMBO J. 2013;32(17):2336\u201347.","journal-title":"EMBO J"},{"issue":"1","key":"555_CR28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2312306120","volume":"121","author":"K Kakuda","year":"2024","unstructured":"Kakuda K, Ikenaka K, Kuma A, Doi J, Aguirre C, Wang N, et al. Lysophagy protects against propagation of alpha-synuclein aggregation through ruptured lysosomal vesicles. Proc Natl Acad Sci USA. 2024;121(1):e2312306120.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7095","key":"555_CR29","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nature04724","volume":"441","author":"T Hara","year":"2006","unstructured":"Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441(7095):885\u20139.","journal-title":"Nature"},{"issue":"7095","key":"555_CR30","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nature04723","volume":"441","author":"M Komatsu","year":"2006","unstructured":"Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441(7095):880\u20134.","journal-title":"Nature"},{"issue":"22","key":"555_CR31","doi-asserted-by":"publisher","first-page":"7585","DOI":"10.1523\/JNEUROSCI.5809-11.2012","volume":"32","author":"LG Friedman","year":"2012","unstructured":"Friedman LG, Lachenmayer ML, Wang J, He L, Poulose SM, Komatsu M, et al. Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of alpha-synuclein and LRRK2 in the brain. J Neurosci. 2012;32(22):7585\u201393.","journal-title":"J Neurosci"},{"issue":"7","key":"555_CR32","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.neuron.2025.01.019","volume":"113","author":"A Karpova","year":"2025","unstructured":"Karpova A, Hiesinger PR, Kuijpers M, Albrecht A, Kirstein J, Andres-Alonso M, et al. Neuronal autophagy in the control of synapse function. Neuron. 2025;113(7):974\u201390.","journal-title":"Neuron"},{"issue":"1","key":"555_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.devcel.2014.06.001","volume":"30","author":"S Maday","year":"2014","unstructured":"Maday S, Holzbaur EL. Autophagosome biogenesis in primary neurons follows an ordered and spatially regulated pathway. Dev Cell. 2014;30(1):71\u201385.","journal-title":"Dev Cell"},{"key":"555_CR34","doi-asserted-by":"publisher","first-page":"e50843","DOI":"10.7554\/eLife.50843","volume":"9","author":"OJ Lieberman","year":"2020","unstructured":"Lieberman OJ, Frier MD, McGuirt AF, Griffey CJ, Rafikian E, Yang M, et al. Cell-type-specific regulation of neuronal intrinsic excitability by macroautophagy. Elife. 2020;9:e50843.","journal-title":"Elife"},{"issue":"2","key":"555_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.neuron.2020.10.005","volume":"109","author":"M Kuijpers","year":"2021","unstructured":"Kuijpers M, Kochlamazashvili G, Stumpf A, Puchkov D, Swaminathan A, Lucht MT, et al. Neuronal autophagy regulates presynaptic neurotransmission by controlling the axonal endoplasmic reticulum. Neuron. 2021;109(2):299\u2013313.","journal-title":"Neuron"},{"issue":"1","key":"555_CR36","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1038\/s41467-024-47440-z","volume":"15","author":"X Zhou","year":"2024","unstructured":"Zhou X, Lee YK, Li X, Kim H, Sanchez-Priego C, Han X, et al. Integrated proteomics reveals autophagy landscape and an autophagy receptor controlling PKA-RI complex homeostasis in neurons. Nat Commun. 2024;15(1):3113.","journal-title":"Nat Commun"},{"issue":"15","key":"555_CR37","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.neuron.2023.05.011","volume":"111","author":"E Kallergi","year":"2023","unstructured":"Kallergi E, Siva Sankar D, Matera A, Kolaxi A, Paolicelli RC, Dengjel J, et al. Profiling of purified autophagic vesicle degradome in the maturing and aging brain. Neuron. 2023;111(15):2329\u201347.","journal-title":"Neuron"},{"issue":"52","key":"555_CR38","doi-asserted-by":"publisher","first-page":"33586","DOI":"10.1073\/pnas.2011870117","volume":"117","author":"Z Taoufiq","year":"2020","unstructured":"Taoufiq Z, Ninov M, Villar-Briones A, Wang HY, Sasaki T, Roy MC, et al. Hidden proteome of synaptic vesicles in the mammalian brain. Proc Natl Acad Sci USA. 2020;117(52):33586\u201396.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"555_CR39","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.neuron.2021.12.031","volume":"110","author":"S Yang","year":"2022","unstructured":"Yang S, Park D, Manning L, Kargbo-Hill SE, Cao M, Xuan Z, et al. Presynaptic autophagy is coupled to the synaptic vesicle cycle via ATG-9. Neuron. 2022;110(5):824\u201340.","journal-title":"Neuron"},{"issue":"17","key":"555_CR40","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1523\/JNEUROSCI.20-17-06365.2000","volume":"20","author":"PJ Kahle","year":"2000","unstructured":"Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, Schindzielorz A, et al. Subcellular localization of wild-type and Parkinson\u2019s disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J Neurosci. 2000;20(17):6365\u201373.","journal-title":"J Neurosci"},{"issue":"4","key":"555_CR41","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neuroscience.2008.01.030","volume":"152","author":"G Muntane","year":"2008","unstructured":"Muntane G, Dalfo E, Martinez A, Ferrer I. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer\u2019s disease, and in Parkinson\u2019s disease and related alpha-synucleinopathies. Neuroscience. 2008;152(4):913\u201323.","journal-title":"Neuroscience"},{"issue":"14","key":"555_CR42","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1093\/hmg\/ddaa080","volume":"29","author":"PY Pan","year":"2020","unstructured":"Pan PY, Sheehan P, Wang Q, Zhu X, Zhang Y, Choi I, et al. Synj1 haploinsufficiency causes dopamine neuron vulnerability and alpha-synuclein accumulation in mice. Hum Mol Genet. 2020;29(14):2300\u201312.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"555_CR43","doi-asserted-by":"publisher","first-page":"4528","DOI":"10.1038\/s41380-023-02242-5","volume":"28","author":"A Litwiniuk","year":"2023","unstructured":"Litwiniuk A, Juszczak GR, Stankiewicz AM, Urbanska K. The role of glial autophagy in Alzheimer\u2019s disease. Mol Psychiatry. 2023;28(11):4528\u201339.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"555_CR44","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","volume":"177","author":"MS Ioannou","year":"2019","unstructured":"Ioannou MS, Jackson J, Sheu SH, Chang CL, Weigel AV, Liu H, et al. Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity. Cell. 2019;177(6):1522\u201335.","journal-title":"Cell"},{"issue":"5","key":"555_CR45","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.cmet.2017.08.024","volume":"26","author":"L Liu","year":"2017","unstructured":"Liu L, MacKenzie KR, Putluri N, Maletic-Savatic M, Bellen HJ. The glia-neuron lactate shuttle and elevated ROS promote lipid synthesis in neurons and lipid droplet accumulation in glia via APOE\/D. Cell Metab. 2017;26(5):719\u201337.","journal-title":"Cell Metab"},{"issue":"7242","key":"555_CR46","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nature07976","volume":"458","author":"R Singh","year":"2009","unstructured":"Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, et al. Autophagy regulates lipid metabolism. Nature. 2009;458(7242):1131\u20135.","journal-title":"Nature"},{"key":"555_CR47","first-page":"1","volume":"22","author":"XY Xie","year":"2025","unstructured":"Xie XY, Wang L, Xie SQ, Zhou GF, Wen QX, Ma YL, et al. Cerebral FURIN deficiency impairs astrocytic lipophagy through ITGAV maturation. Autophagy. 2025;22:1\u201322.","journal-title":"Autophagy"},{"issue":"6","key":"555_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115809","volume":"44","author":"JH Howden","year":"2025","unstructured":"Howden JH, Hakansson H, Nieto-Rostro M, McAdam R, Arber C, Brandon NJ, et al. Hexokinase 2 interacts with PINK1 to facilitate mitophagy in astrocytes and restrain inflammation-induced neurotoxicity. Cell Rep. 2025;44(6):115809.","journal-title":"Cell Rep"},{"issue":"11","key":"555_CR49","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/mp.2016.103","volume":"22","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Cho MH, Shim WH, Kim JK, Jeon EY, Kim DH, et al. Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects. Mol Psychiatry. 2017;22(11):1576\u201384.","journal-title":"Mol Psychiatry"},{"issue":"6048","key":"555_CR50","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1202529","volume":"333","author":"RC Paolicelli","year":"2011","unstructured":"Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333(6048):1456\u20138.","journal-title":"Science"},{"issue":"12","key":"555_CR51","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1080\/15548627.2020.1719723","volume":"16","author":"J Cheng","year":"2020","unstructured":"Cheng J, Liao Y, Dong Y, Hu H, Yang N, Kong X, et al. Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice. Autophagy. 2020;16(12):2193\u2013205.","journal-title":"Autophagy"},{"issue":"27","key":"555_CR52","doi-asserted-by":"publisher","first-page":"e2023418118","DOI":"10.1073\/pnas.2023418118","volume":"118","author":"Y Xu","year":"2021","unstructured":"Xu Y, Propson NE, Du S, Xiong W, Zheng H. Autophagy deficiency modulates microglial lipid homeostasis and aggravates tau pathology and spreading. Proc Natl Acad Sci USA. 2021;118(27):e2023418118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"555_CR53","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41556-025-01654-5","volume":"27","author":"S Singh","year":"2025","unstructured":"Singh S, Carosi JM, Dang L, Sargeant TJ. Autophagy does not always decline with ageing. Nat Cell Biol. 2025;27(5):712\u20135.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"555_CR54","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/archneur.60.4.529","volume":"60","author":"NJ Diederich","year":"2003","unstructured":"Diederich NJ, Moore CG, Leurgans SE, Chmura TA, Goetz CG. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset. Arch Neurol. 2003;60(4):529\u201333.","journal-title":"Arch Neurol"},{"issue":"5","key":"555_CR55","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1212\/01.wnl.0000341769.50075.bb","volume":"72","author":"JA Driver","year":"2009","unstructured":"Driver JA, Logroscino G, Gaziano JM, Kurth T. Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology. 2009;72(5):432\u20138.","journal-title":"Neurology"},{"issue":"5","key":"555_CR56","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41418-021-00903-y","volume":"29","author":"SJ Park","year":"2022","unstructured":"Park SJ, Frake RA, Karabiyik C, Son SM, Siddiqi FH, Bento CF, et al. Vinexin contributes to autophagic decline in brain ageing across species. Cell Death Differ. 2022;29(5):1055\u201370.","journal-title":"Cell Death Differ"},{"issue":"32","key":"555_CR57","doi-asserted-by":"publisher","first-page":"14164","DOI":"10.1073\/pnas.1009485107","volume":"107","author":"MM Lipinski","year":"2010","unstructured":"Lipinski MM, Zheng B, Lu T, Yan Z, Py BF, Ng A, et al. Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2010;107(32):14164\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"555_CR58","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1038\/s44318-024-00241-y","volume":"43","author":"A Rappe","year":"2024","unstructured":"Rappe A, Vihinen HA, Suomi F, Hassinen AJ, Ehsan H, Jokitalo ES, et al. Longitudinal autophagy profiling of the mammalian brain reveals sustained mitophagy throughout healthy aging. EMBO J. 2024;43(23):6199\u2013231.","journal-title":"EMBO J"},{"issue":"5","key":"555_CR59","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/15548627.2016.1159376","volume":"12","author":"T Yamamoto","year":"2016","unstructured":"Yamamoto T, Takabatake Y, Kimura T, Takahashi A, Namba T, Matsuda J, et al. Time-dependent dysregulation of autophagy: Implications in aging and mitochondrial homeostasis in the kidney proximal tubule. Autophagy. 2016;12(5):801\u201313.","journal-title":"Autophagy"},{"issue":"7","key":"555_CR60","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41556-023-01158-0","volume":"25","author":"I Choi","year":"2023","unstructured":"Choi I, Wang M, Yoo S, Xu P, Seegobin SP, Li X, et al. Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence. Nat Cell Biol. 2023;25(7):963\u201374.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"555_CR61","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1038\/s41467-020-17985-w","volume":"11","author":"T Yamamuro","year":"2020","unstructured":"Yamamuro T, Kawabata T, Fukuhara A, Saita S, Nakamura S, Takeshita H, et al. Age-dependent loss of adipose Rubicon promotes metabolic disorders via excess autophagy. Nat Commun. 2020;11(1):4150.","journal-title":"Nat Commun"},{"issue":"8077","key":"555_CR62","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41586-025-09234-1","volume":"644","author":"Y Wang","year":"2025","unstructured":"Wang Y, Eapen VV, Liang Y, Kournoutis A, Sherman MS, Xu Y, et al. WSTF nuclear autophagy regulates chronic but not acute inflammation. Nature. 2025;644(8077):780\u20139.","journal-title":"Nature"},{"issue":"1","key":"555_CR63","doi-asserted-by":"publisher","DOI":"10.1080\/27694127.2025.2577406","volume":"4","author":"E Birnbaum","year":"2025","unstructured":"Birnbaum E, Yue Z. The role of autophagy in synucleinopathy: clearance versus spread of alpha-synuclein. Autophagy Rep. 2025;4(1):2577406.","journal-title":"Autophagy Rep"},{"issue":"9440","key":"555_CR64","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, et al. Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet. 2004;364(9440):1167\u20139.","journal-title":"Lancet"},{"issue":"12","key":"555_CR65","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ng.485","volume":"41","author":"W Satake","year":"2009","unstructured":"Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease. Nat Genet. 2009;41(12):1303\u20137.","journal-title":"Nat Genet"},{"issue":"12","key":"555_CR66","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Simon-Sanchez","year":"2009","unstructured":"Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, et al. Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet. 2009;41(12):1308\u201312.","journal-title":"Nat Genet"},{"issue":"9440","key":"555_CR67","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","volume":"364","author":"P Ibanez","year":"2004","unstructured":"Ibanez P, Bonnet AM, Debarges B, Lohmann E, Tison F, Pollak P, et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson\u2019s disease. Lancet. 2004;364(9440):1169\u201371.","journal-title":"Lancet"},{"issue":"5321","key":"555_CR68","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science. 1997;276(5321):2045\u20137.","journal-title":"Science"},{"issue":"5646","key":"555_CR69","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. Alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science. 2003;302(5646):841.","journal-title":"Science"},{"issue":"Suppl","key":"555_CR70","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1046\/j.1440-1789.2000.00312.x","volume":"20","author":"N Hattori","year":"2000","unstructured":"Hattori N, Shimura H, Kubo S, Kitada T, Wang M, Asakawa S, et al. Autosomal recessive juvenile parkinsonism: a key to understanding nigral degeneration in sporadic Parkinson\u2019s disease. Neuropathology. 2000;20(Suppl):S85\u201390.","journal-title":"Neuropathology"},{"issue":"6676","key":"555_CR71","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392(6676):605\u20138.","journal-title":"Nature"},{"issue":"7","key":"555_CR72","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/mds.24962","volume":"27","author":"M Poulopoulos","year":"2012","unstructured":"Poulopoulos M, Levy OA, Alcalay RN. The neuropathology of genetic Parkinson\u2019s disease. Mov Disord. 2012;27(7):831\u201342.","journal-title":"Mov Disord"},{"issue":"5674","key":"555_CR73","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, et al. Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science. 2004;304(5674):1158\u201360.","journal-title":"Science"},{"issue":"Pt 6","key":"555_CR74","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/brain\/aww080","volume":"139","author":"R Taipa","year":"2016","unstructured":"Taipa R, Pereira C, Reis I, Alonso I, Bastos-Lima A, Melo-Pires M, et al. DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology. Brain. 2016;139(Pt 6):1680\u20137.","journal-title":"Brain"},{"issue":"3","key":"555_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002548","volume":"8","author":"CM Lill","year":"2012","unstructured":"Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson\u2019s disease genetics: the PDGene database. PLoS Genet. 2012;8(3):e1002548.","journal-title":"PLoS Genet"},{"issue":"4","key":"555_CR76","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1212\/WNL.0b013e318227042d","volume":"77","author":"C Marras","year":"2011","unstructured":"Marras C, Schule B, Munhoz RP, Rogaeva E, Langston JW, Kasten M, et al. Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology. 2011;77(4):325\u201333.","journal-title":"Neurology"},{"issue":"3","key":"555_CR77","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ana.10113","volume":"51","author":"M Funayama","year":"2002","unstructured":"Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F. A new locus for Parkinson\u2019s disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol. 2002;51(3):296\u2013301.","journal-title":"Ann Neurol"},{"issue":"4","key":"555_CR78","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004;44(4):601\u20137.","journal-title":"Neuron"},{"issue":"4","key":"555_CR79","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Paisan-Ruiz","year":"2004","unstructured":"Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron. 2004;44(4):595\u2013600.","journal-title":"Neuron"},{"issue":"16","key":"555_CR80","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1212\/WNL.0000000000012705","volume":"97","author":"HF Chien","year":"2021","unstructured":"Chien HF, Rodriguez RD, Bonifati V, Nitrini R, Pasqualucci CA, Gelpi E, et al. Neuropathologic findings in a patient with juvenile-onset levodopa-responsive parkinsonism due to ATP13A2 mutation. Neurology. 2021;97(16):763\u20136.","journal-title":"Neurology"},{"issue":"1","key":"555_CR81","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ana.21415","volume":"65","author":"C Paisan-Ruiz","year":"2009","unstructured":"Paisan-Ruiz C, Bhatia KP, Li A, Hernandez D, Davis M, Wood NW, et al. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol. 2009;65(1):19\u201323.","journal-title":"Ann Neurol"},{"issue":"4","key":"555_CR82","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.neurobiolaging.2010.05.009","volume":"33","author":"C Paisan-Ruiz","year":"2012","unstructured":"Paisan-Ruiz C, Li A, Schneider SA, Holton JL, Johnson R, Kidd D, et al. Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging. 2012;33(4):814\u201323.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"555_CR83","doi-asserted-by":"publisher","first-page":"1222 e1","DOI":"10.1016\/j.neurobiolaging.2014.09.005","volume":"36","author":"DA Dyment","year":"2015","unstructured":"Dyment DA, Smith AC, Humphreys P, Schwartzentruber J, Beaulieu CL, Consortium FC, et al. Homozygous nonsense mutation in SYNJ1 associated with intractable epilepsy and tau pathology. Neurobiol Aging. 2015;36(2):1222\u20131225.","journal-title":"Neurobiol Aging"},{"issue":"9","key":"555_CR84","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/humu.22373","volume":"34","author":"M Quadri","year":"2013","unstructured":"Quadri M, Fang M, Picillo M, Olgiati S, Breedveld GJ, Graafland J, et al. Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism. Hum Mutat. 2013;34(9):1208\u201315.","journal-title":"Hum Mutat"},{"issue":"5","key":"555_CR85","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/ana.20831","volume":"59","author":"G Davidzon","year":"2006","unstructured":"Davidzon G, Greene P, Mancuso M, Klos KJ, Ahlskog JE, Hirano M, et al. Early-onset familial parkinsonism due to POLG mutations. Ann Neurol. 2006;59(5):859\u201362.","journal-title":"Ann Neurol"},{"issue":"9437","key":"555_CR86","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(04)16983-3","volume":"364","author":"P Luoma","year":"2004","unstructured":"Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, Chalmers RM, et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet. 2004;364(9437):875\u201382.","journal-title":"Lancet"},{"issue":"1","key":"555_CR87","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","volume":"89","author":"C Vilarino-Guell","year":"2011","unstructured":"Vilarino-Guell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lincoln SJ, et al. VPS35 mutations in Parkinson disease. Am J Hum Genet. 2011;89(1):162\u20137.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"555_CR88","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","volume":"89","author":"A Zimprich","year":"2011","unstructured":"Zimprich A, Benet-Pages A, Struhal W, Graf E, Eck SH, Offman MN, et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet. 2011;89(1):168\u201375.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"555_CR89","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ajhg.2016.01.014","volume":"98","author":"S Lesage","year":"2016","unstructured":"Lesage S, Drouet V, Majounie E, Deramecourt V, Jacoupy M, Nicolas A, et al. Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1\/Parkin-dependent mitophagy. Am J Hum Genet. 2016;98(3):500\u201313.","journal-title":"Am J Hum Genet"},{"issue":"5999","key":"555_CR90","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burre","year":"2010","unstructured":"Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Sudhof TC. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science. 2010;329(5999):1663\u20137.","journal-title":"Science"},{"issue":"4","key":"555_CR91","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1074\/jbc.M008919200","volume":"276","author":"BI Giasson","year":"2001","unstructured":"Giasson BI, Murray IV, Trojanowski JQ, Lee VM. A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem. 2001;276(4):2380\u20136.","journal-title":"J Biol Chem"},{"issue":"6109","key":"555_CR92","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O\u2019Brien P, Trojanowski JQ, et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012;338(6109):949\u201353.","journal-title":"Science"},{"issue":"11","key":"555_CR93","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med. 1998;4(11):1318\u201320.","journal-title":"Nat Med"},{"issue":"5688","key":"555_CR94","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004;305(5688):1292\u20135.","journal-title":"Science"},{"issue":"2","key":"555_CR95","first-page":"777","volume":"118","author":"M Martinez-Vicente","year":"2008","unstructured":"Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV, et al. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest. 2008;118(2):777\u201388.","journal-title":"J Clin Invest"},{"issue":"5910","key":"555_CR96","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.1166088","volume":"323","author":"Q Yang","year":"2009","unstructured":"Yang Q, She H, Gearing M, Colla E, Lee M, Shacka JJ, et al. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science. 2009;323(5910):124\u20137.","journal-title":"Science"},{"issue":"5","key":"555_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000301","volume":"17","author":"P Kirchner","year":"2019","unstructured":"Kirchner P, Bourdenx M, Madrigal-Matute J, Tiano S, Diaz A, Bartholdy BA, et al. Proteome-wide analysis of chaperone-mediated autophagy targeting motifs. PLoS Biol. 2019;17(5):e3000301.","journal-title":"PLoS Biol"},{"key":"555_CR98","doi-asserted-by":"publisher","first-page":"e56825","DOI":"10.7554\/eLife.56825","volume":"9","author":"G Suzuki","year":"2020","unstructured":"Suzuki G, Imura S, Hosokawa M, Katsumata R, Nonaka T, Hisanaga SI, et al. Alpha-synuclein strains that cause distinct pathologies differentially inhibit proteasome. Elife. 2020;9:e56825.","journal-title":"Elife"},{"issue":"21","key":"555_CR99","doi-asserted-by":"publisher","first-page":"15194","DOI":"10.1074\/jbc.M113.457408","volume":"288","author":"SA Tanik","year":"2013","unstructured":"Tanik SA, Schultheiss CE, Volpicelli-Daley LA, Brunden KR, Lee VM. Lewy body-like alpha-synuclein aggregates resist degradation and impair macroautophagy. J Biol Chem. 2013;288(21):15194\u2013210.","journal-title":"J Biol Chem"},{"issue":"1","key":"555_CR100","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1038\/s41598-018-21325-w","volume":"8","author":"S Sato","year":"2018","unstructured":"Sato S, Uchihara T, Fukuda T, Noda S, Kondo H, Saiki S, et al. Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice. Sci Rep. 2018;8(1):2813.","journal-title":"Sci Rep"},{"issue":"1","key":"555_CR101","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00441-018-2839-5","volume":"373","author":"W Peelaerts","year":"2018","unstructured":"Peelaerts W, Bousset L, Baekelandt V, Melki R. A-synuclein strains and seeding in Parkinson\u2019s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences. Cell Tissue Res. 2018;373(1):195\u2013212.","journal-title":"Cell Tissue Res"},{"issue":"12","key":"555_CR102","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","volume":"62","author":"E Kuusisto","year":"2003","unstructured":"Kuusisto E, Parkkinen L, Alafuzoff I. Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol. 2003;62(12):1241\u201353.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"45","key":"555_CR103","doi-asserted-by":"publisher","first-page":"44405","DOI":"10.1074\/jbc.M308041200","volume":"278","author":"GK Tofaris","year":"2003","unstructured":"Tofaris GK, Razzaq A, Ghetti B, Lilley KS, Spillantini MG. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J Biol Chem. 2003;278(45):44405\u201311.","journal-title":"J Biol Chem"},{"issue":"12","key":"555_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052868","volume":"7","author":"Y Watanabe","year":"2012","unstructured":"Watanabe Y, Tatebe H, Taguchi K, Endo Y, Tokuda T, Mizuno T, et al. p62\/SQSTM1-dependent autophagy of Lewy body-like alpha-synuclein inclusions. PLoS ONE. 2012;7(12):e52868.","journal-title":"PLoS ONE"},{"issue":"12","key":"555_CR105","doi-asserted-by":"publisher","first-page":"10814","DOI":"10.1074\/jbc.M110.132514","volume":"286","author":"V Choubey","year":"2011","unstructured":"Choubey V, Safiulina D, Vaarmann A, Cagalinec M, Wareski P, Kuum M, et al. Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy. J Biol Chem. 2011;286(12):10814\u201324.","journal-title":"J Biol Chem"},{"issue":"7565","key":"555_CR106","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature14893","volume":"524","author":"M Lazarou","year":"2015","unstructured":"Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524(7565):309\u201314.","journal-title":"Nature"},{"issue":"5","key":"555_CR107","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1083\/jcb.200809125","volume":"183","author":"D Narendra","year":"2008","unstructured":"Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 2008;183(5):795\u2013803.","journal-title":"J Cell Biol"},{"issue":"1","key":"555_CR108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000298","volume":"8","author":"DP Narendra","year":"2010","unstructured":"Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010;8(1):e1000298.","journal-title":"PLoS Biol"},{"issue":"6","key":"555_CR109","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1073\/pnas.0409598102","volume":"102","author":"FA Perez","year":"2005","unstructured":"Perez FA, Palmiter RD. Parkin-deficient mice are not a robust model of parkinsonism. Proc Natl Acad Sci USA. 2005;102(6):2174\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"555_CR110","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neures.2020.03.014","volume":"159","author":"S Sato","year":"2020","unstructured":"Sato S, Noda S, Hattori N. Pathogenic insights to Parkin-linked model mice. Neurosci Res. 2020;159:47\u201351.","journal-title":"Neurosci Res"},{"issue":"10","key":"555_CR111","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41556-024-01513-9","volume":"26","author":"DP Narendra","year":"2024","unstructured":"Narendra DP, Youle RJ. The role of PINK1-Parkin in mitochondrial quality control. Nat Cell Biol. 2024;26(10):1639\u201351.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"555_CR112","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.neuron.2015.06.034","volume":"87","author":"AM Pickrell","year":"2015","unstructured":"Pickrell AM, Huang CH, Kennedy SR, Ordureau A, Sideris DP, Hoekstra JG, et al. Endogenous Parkin preserves dopaminergic substantia nigral neurons following mitochondrial DNA mutagenic stress. Neuron. 2015;87(2):371\u201381.","journal-title":"Neuron"},{"issue":"38","key":"555_CR113","doi-asserted-by":"publisher","first-page":"14503","DOI":"10.1073\/pnas.0803998105","volume":"105","author":"H Deng","year":"2008","unstructured":"Deng H, Dodson MW, Huang H, Guo M. The Parkinson\u2019s disease genes PINK1 and Parkin promote mitochondrial fission and\/or inhibit fusion in Drosophila. Proc Natl Acad Sci USA. 2008;105(38):14503\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8055","key":"555_CR114","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41586-025-08590-2","volume":"639","author":"T Yamada","year":"2025","unstructured":"Yamada T, Ikeda A, Murata D, Wang H, Zhang C, Khare P, et al. Dual regulation of mitochondrial fusion by Parkin-PINK1 and OMA1. Nature. 2025;639(8055):776\u201383.","journal-title":"Nature"},{"issue":"4","key":"555_CR115","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41422-019-0142-y","volume":"29","author":"W Yang","year":"2019","unstructured":"Yang W, Liu Y, Tu Z, Xiao C, Yan S, Ma X, et al. CRISPR\/Cas9-mediated PINK1 deletion leads to neurodegeneration in rhesus monkeys. Cell Res. 2019;29(4):334\u20136.","journal-title":"Cell Res"},{"issue":"10","key":"555_CR116","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1083\/jcb.201807019","volume":"217","author":"N Kumar","year":"2018","unstructured":"Kumar N, Leonzino M, Hancock-Cerutti W, Horenkamp FA, Li P, Lees JA, et al. VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites. J Cell Biol. 2018;217(10):3625\u201339.","journal-title":"J Cell Biol"},{"issue":"3","key":"555_CR117","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ygeno.2004.04.012","volume":"84","author":"A Velayos-Baeza","year":"2004","unstructured":"Velayos-Baeza A, Vettori A, Copley RR, Dobson-Stone C, Monaco AP. Analysis of the human VPS13 gene family. Genomics. 2004;84(3):536\u201349.","journal-title":"Genomics"},{"issue":"7","key":"555_CR118","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202211039","volume":"222","author":"R Dabrowski","year":"2023","unstructured":"Dabrowski R, Tulli S, Graef M. Parallel phospholipid transfer by Vps13 and Atg2 determines autophagosome biogenesis dynamics. J Cell Biol.\u00a02023;222(7):e202211039.","journal-title":"J Cell Biol"},{"issue":"5","key":"555_CR119","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41556-025-01653-6","volume":"27","author":"X Wang","year":"2025","unstructured":"Wang X, Xu P, Bentley-DeSousa A, Hancock-Cerutti W, Cai S, Johnson BT, et al. The bridge-like lipid transport protein VPS13C\/PARK23 mediates ER-lysosome contacts following lysosome damage. Nat Cell Biol. 2025;27(5):776\u201389.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"555_CR120","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202304042","volume":"223","author":"LF Schr\u04e7der","year":"2024","unstructured":"Schr\u04e7der LF, Peng W, Gao G, Wong YC, Schwake M, Krainc D. VPS13C regulates phospho-Rab10-mediated lysosomal function in human dopaminergic neurons. J Cell Biol.\u00a02024;223(5):e202304042.","journal-title":"J Cell Biol"},{"issue":"7","key":"555_CR121","doi-asserted-by":"publisher","first-page":"e202106046","DOI":"10.1083\/jcb.202106046","volume":"221","author":"W Hancock-Cerutti","year":"2022","unstructured":"Hancock-Cerutti W, Wu Z, Xu P, Yadavalli N, Leonzino M, Tharkeshwar AK, et al. ER-lysosome lipid transfer protein VPS13C\/PARK23 prevents aberrant mtDNA-dependent STING signaling. J Cell Biol. 2022;221(7):e202106046.","journal-title":"J Cell Biol"},{"issue":"3","key":"555_CR122","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/jamaneurol.2017.4019","volume":"75","author":"R Saunders-Pullman","year":"2018","unstructured":"Saunders-Pullman R, Mirelman A, Alcalay RN, Wang C, Ortega RA, Raymond D, et al. Progression in the LRRK2-asssociated parkinson disease population. JAMA Neurol. 2018;75(3):312\u20139.","journal-title":"JAMA Neurol"},{"issue":"46","key":"555_CR123","doi-asserted-by":"publisher","first-page":"16842","DOI":"10.1073\/pnas.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA, et al. Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA. 2005;102(46):16842\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"555_CR124","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1001\/jamaneurol.2018.1885","volume":"75","author":"C Blauwendraat","year":"2018","unstructured":"Blauwendraat C, Reed X, Kia DA, Gan-Or Z, Lesage S, Pihlstrom L, et al. Frequency of loss of function variants in LRRK2 in Parkinson disease. JAMA Neurol. 2018;75(11):1416\u201322.","journal-title":"JAMA Neurol"},{"issue":"7","key":"555_CR125","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M, O\u2019Sullivan SS, Bonifati V, Durr A, Bressman S, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol. 2008;7(7):583\u201390.","journal-title":"Lancet Neurol"},{"issue":"10","key":"555_CR126","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.cub.2021.02.061","volume":"31","author":"CA Boecker","year":"2021","unstructured":"Boecker CA, Goldsmith J, Dou D, Cajka GG, Holzbaur ELF. Increased LRRK2 kinase activity alters neuronal autophagy by disrupting the axonal transport of autophagosomes. Curr Biol. 2021;31(10):2140\u201354.","journal-title":"Curr Biol"},{"issue":"1","key":"555_CR127","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00018-012-1061-y","volume":"70","author":"JM Bravo-San Pedro","year":"2013","unstructured":"Bravo-San Pedro JM, Niso-Santano M, Gomez-Sanchez R, Pizarro-Estrella E, Aiastui-Pujana A, Gorostidi A, et al. The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK\/ERK pathway. Cell Mol Life Sci. 2013;70(1):121\u201336.","journal-title":"Cell Mol Life Sci"},{"key":"555_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-020-0279-y","volume":"6","author":"J Obergasteiger","year":"2020","unstructured":"Obergasteiger J, Frapporti G, Lamonaca G, Pizzi S, Picard A, Lavdas AA, et al. Kinase inhibition of G2019S-LRRK2 enhances autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions. Cell Death Discov. 2020;6:45.","journal-title":"Cell Death Discov"},{"issue":"21","key":"555_CR129","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1093\/hmg\/ddr348","volume":"20","author":"MC Herzig","year":"2011","unstructured":"Herzig MC, Kolly C, Persohn E, Theil D, Schweizer T, Hafner T, et al. LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice. Hum Mol Genet. 2011;20(21):4209\u201323.","journal-title":"Hum Mol Genet"},{"issue":"21","key":"555_CR130","doi-asserted-by":"publisher","first-page":"9879","DOI":"10.1073\/pnas.1004676107","volume":"107","author":"Y Tong","year":"2010","unstructured":"Tong Y, Yamaguchi H, Giaime E, Boyle S, Kopan R, Kelleher RJ 3rd, et al. Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc Natl Acad Sci USA. 2010;107(21):9879\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"31","key":"555_CR131","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2303789120","volume":"120","author":"N Yadavalli","year":"2023","unstructured":"Yadavalli N, Ferguson SM. LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition. Proc Natl Acad Sci USA. 2023;120(31):e2303789120.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"39","key":"555_CR132","doi-asserted-by":"publisher","first-page":"E9115","DOI":"10.1073\/pnas.1812196115","volume":"115","author":"T Eguchi","year":"2018","unstructured":"Eguchi T, Kuwahara T, Sakurai M, Komori T, Fujimoto T, Ito G, et al. LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis. Proc Natl Acad Sci USA. 2018;115(39):E9115\u201324.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"555_CR133","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202310150","volume":"224","author":"A Bentley-DeSousa","year":"2025","unstructured":"Bentley-DeSousa A, Roczniak-Ferguson A, Ferguson SM. A STING-CASM-GABARAP pathway activates LRRK2 at lysosomes. J Cell Biol.\u00a02025;224(2):e202310150.","journal-title":"J Cell Biol"},{"issue":"3","key":"555_CR134","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202302067","volume":"223","author":"T Eguchi","year":"2024","unstructured":"Eguchi T, Sakurai M, Wang Y, Saito C, Yoshii G, Wileman T, et al. The V-ATPase-ATG16L1 axis recruits LRRK2 to facilitate the lysosomal stress response. J Cell Biol.\u00a02024;223(3):e202302067.","journal-title":"J Cell Biol"},{"issue":"3","key":"555_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112221","volume":"42","author":"F Filippini","year":"2023","unstructured":"Filippini F, Nola S, Zahraoui A, Roger K, Esmaili M, Sun J, et al. Secretion of VGF relies on the interplay between LRRK2 and post-Golgi v-SNAREs. Cell Rep. 2023;42(3):112221.","journal-title":"Cell Rep"},{"issue":"3","key":"555_CR136","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41593-024-01866-2","volume":"28","author":"X Yuan","year":"2025","unstructured":"Yuan X, Nie S, Yang Y, Liu C, Xia D, Meng L, et al. Propagation of pathologic alpha-synuclein from kidney to brain may contribute to Parkinson\u2019s disease. Nat Neurosci. 2025;28(3):577\u201388.","journal-title":"Nat Neurosci"},{"key":"555_CR137","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.40202","volume":"7","author":"HS Dhekne","year":"2018","unstructured":"Dhekne HS, Yanatori I, Gomez RC, Tonelli F, Diez F, Schule B, et al. A pathway for Parkinson\u2019s disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain. Elife.\u00a02018;7:e40202.","journal-title":"Elife"},{"issue":"1","key":"555_CR138","doi-asserted-by":"publisher","first-page":"8434","DOI":"10.1038\/s41467-024-52723-6","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, Zhu H, Huang BT, Li X, Kim H, Tan H, et al. RAB12-LRRK2 complex suppresses primary ciliogenesis and regulates centrosome homeostasis in astrocytes. Nat Commun. 2024;15(1):8434.","journal-title":"Nat Commun"},{"issue":"893","key":"555_CR139","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.ads5761","volume":"18","author":"E Jaimon","year":"2025","unstructured":"Jaimon E, Lin YE, Tonelli F, Antico O, Alessi DR, Pfeffer SR. Restoration of striatal neuroprotective pathways by kinase inhibitor treatment of Parkinson\u2019s disease-linked LRRK2-mutant mice. Sci Signal. 2025;18(893):eads5761.","journal-title":"Sci Signal"},{"key":"555_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2016.01.008","volume":"39","author":"O Pampliega","year":"2016","unstructured":"Pampliega O, Cuervo AM. Autophagy and primary cilia: dual interplay. Curr Opin Cell Biol. 2016;39:1\u20137.","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"555_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23599-7","volume":"12","author":"Y Yamamoto","year":"2021","unstructured":"Yamamoto Y, Chino H, Tsukamoto S, Ode KL, Ueda HR, Mizushima N. NEK9 regulates primary cilia formation by acting as a selective autophagy adaptor for MYH9\/myosin IIA. Nat Commun. 2021;12(1):3292.","journal-title":"Nat Commun"},{"issue":"9","key":"555_CR142","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.4049\/jimmunol.1000548","volume":"185","author":"A Gardet","year":"2010","unstructured":"Gardet A, Benita Y, Li C, Sands BE, Ballester I, Stevens C, et al. LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol. 2010;185(9):5577\u201385.","journal-title":"J Immunol"},{"key":"555_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9255","volume":"6","author":"I Choi","year":"2015","unstructured":"Choi I, Kim B, Byun JW, Baik SH, Huh YH, Kim JH, et al. LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase. Nat Commun. 2015;6:8255.","journal-title":"Nat Commun"},{"issue":"19","key":"555_CR144","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa033277","volume":"351","author":"J Aharon-Peretz","year":"2004","unstructured":"Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson\u2019s disease in Ashkenazi Jews. N Engl J Med. 2004;351(19):1972\u20137.","journal-title":"N Engl J Med"},{"issue":"17","key":"555_CR145","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med. 2009;361(17):1651\u201361.","journal-title":"N Engl J Med"},{"issue":"1","key":"555_CR146","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00401-024-02699-w","volume":"147","author":"RL Walton","year":"2024","unstructured":"Walton RL, Koga S, Beasley AI, White LJ, Griesacker T, Murray ME, et al. Role of GBA variants in Lewy body disease neuropathology. Acta Neuropathol. 2024;147(1):54.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"555_CR147","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1212\/01.wnl.0000327823.81237.d1","volume":"72","author":"WC Nichols","year":"2009","unstructured":"Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, Halter CA, et al. Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. Neurology. 2009;72(4):310\u20136.","journal-title":"Neurology"},{"issue":"Pt 2","key":"555_CR148","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/brain\/aws318","volume":"136","author":"SE Winder-Rhodes","year":"2013","unstructured":"Winder-Rhodes SE, Evans JR, Ban M, Mason SL, Williams-Gray CH, Foltynie T, et al. Glucocerebrosidase mutations influence the natural history of Parkinson\u2019s disease in a community-based incident cohort. Brain. 2013;136(Pt 2):392\u20139.","journal-title":"Brain"},{"issue":"9","key":"555_CR149","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1212\/WNL.0000000000001315","volume":"84","author":"Z Gan-Or","year":"2015","unstructured":"Gan-Or Z, Amshalom I, Kilarski LL, Bar-Shira A, Gana-Weisz M, Mirelman A, et al. Differential effects of severe vs mild GBA mutations on Parkinson disease. Neurology. 2015;84(9):880\u20137.","journal-title":"Neurology"},{"key":"555_CR150","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.parkreldis.2018.05.009","volume":"55","author":"A Thaler","year":"2018","unstructured":"Thaler A, Bregman N, Gurevich T, Shiner T, Dror Y, Zmira O, et al. Parkinson\u2019s disease phenotype is influenced by the severity of the mutations in the GBA gene. Parkinsonism Relat Disord. 2018;55:45\u20139.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"555_CR151","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41531-022-00397-6","volume":"8","author":"A Navarro-Romero","year":"2022","unstructured":"Navarro-Romero A, Fernandez-Gonzalez I, Riera J, Montpeyo M, Albert-Bayo M, Lopez-Royo T, et al. Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology. NPJ Parkinsons Dis. 2022;8(1):126.","journal-title":"NPJ Parkinsons Dis"},{"issue":"6","key":"555_CR152","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cmet.2013.04.014","volume":"17","author":"LD Osellame","year":"2013","unstructured":"Osellame LD, Rahim AA, Hargreaves IP, Gegg ME, Richard-Londt A, Brandner S, et al. Mitochondria and quality control defects in a mouse model of Gaucher disease\u2013links to Parkinson\u2019s disease. Cell Metab. 2013;17(6):941\u201353.","journal-title":"Cell Metab"},{"key":"555_CR153","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1038\/ncomms5028","volume":"5","author":"DC Schondorf","year":"2014","unstructured":"Schondorf DC, Aureli M, McAllister FE, Hindley CJ, Mayer F, Schmid B, et al. iPSC-derived neurons from GBA1-associated Parkinson\u2019s disease patients show autophagic defects and impaired calcium homeostasis. Nat Commun. 2014;5:4028.","journal-title":"Nat Commun"},{"issue":"7","key":"555_CR154","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/sctm.20-0386","volume":"10","author":"MP Srikanth","year":"2021","unstructured":"Srikanth MP, Jones JW, Kane M, Awad O, Park TS, Zambidis ET, et al. Elevated glucosylsphingosine in Gaucher disease induced pluripotent stem cell neurons deregulates lysosomal compartment through mammalian target of rapamycin complex 1. Stem Cells Transl Med. 2021;10(7):1081\u201394.","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"555_CR155","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm6393","volume":"8","author":"SH Kuo","year":"2022","unstructured":"Kuo SH, Tasset I, Cheng MM, Diaz A, Pan MK, Lieberman OJ, et al. Mutant glucocerebrosidase impairs alpha-synuclein degradation by blockade of chaperone-mediated autophagy. Sci Adv. 2022;8(6):eabm6393.","journal-title":"Sci Adv"},{"issue":"1","key":"555_CR156","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"JR Mazzulli","year":"2011","unstructured":"Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA, et al. Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell. 2011;146(1):37\u201352.","journal-title":"Cell"},{"key":"555_CR157","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13024-015-0010-2","volume":"10","author":"D Chiasserini","year":"2015","unstructured":"Chiasserini D, Paciotti S, Eusebi P, Persichetti E, Tasegian A, Kurzawa-Akanbi M, et al. Selective loss of glucocerebrosidase activity in sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Mol Neurodegener. 2015;10:15.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"555_CR158","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00401-012-0975-7","volume":"124","author":"S Odagiri","year":"2012","unstructured":"Odagiri S, Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K. Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in alpha-synucleinopathy. Acta Neuropathol. 2012;124(2):173\u201386.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"555_CR159","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.nbd.2011.05.022","volume":"43","author":"K Tanji","year":"2011","unstructured":"Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K. Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease. Neurobiol Dis. 2011;43(3):690\u20137.","journal-title":"Neurobiol Dis"},{"issue":"7","key":"555_CR160","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian SH, Lewis AJ, Genoud C, Hench J, Moors TE, Navarro PP, et al. Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat Neurosci. 2019;22(7):1099\u2013109.","journal-title":"Nat Neurosci"},{"issue":"19","key":"555_CR161","doi-asserted-by":"publisher","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","volume":"110","author":"M Decressac","year":"2013","unstructured":"Decressac M, Mattsson B, Weikop P, Lundblad M, Jakobsson J, Bjorklund A. TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proc Natl Acad Sci USA. 2013;110(19):E1817\u201326.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"555_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25474-x","volume":"12","author":"J Gordevicius","year":"2021","unstructured":"Gordevicius J, Li P, Marshall LL, Killinger BA, Lang S, Ensink E, et al. Epigenetic inactivation of the autophagy-lysosomal system in appendix in Parkinson\u2019s disease. Nat Commun. 2021;12(1):5134.","journal-title":"Nat Commun"},{"issue":"1","key":"555_CR163","doi-asserted-by":"publisher","first-page":"10490","DOI":"10.1038\/s41467-025-65489-2","volume":"16","author":"J Hallqvist","year":"2025","unstructured":"Hallqvist J, Toomey CE, Pinto R, Baldwin T, Doykov I, Wernick A, et al. Multi-omic analysis reveals lipid dysregulation associated with mitochondrial dysfunction in parkinson\u2019s disease brain. Nat Commun. 2025;16(1):10490.","journal-title":"Nat Commun"},{"issue":"2","key":"555_CR164","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger J, Iram T, Zardeneta M, Lee SE, Lehallier B, Haney MS, et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci. 2020;23(2):194\u2013208.","journal-title":"Nat Neurosci"},{"issue":"6","key":"555_CR165","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/15548627.2015.1034410","volume":"11","author":"LR Lapierre","year":"2015","unstructured":"Lapierre LR, Kumsta C, Sandri M, Ballabio A, Hansen M. Transcriptional and epigenetic regulation of autophagy in aging. Autophagy. 2015;11(6):867\u201380.","journal-title":"Autophagy"},{"issue":"1","key":"555_CR166","doi-asserted-by":"publisher","first-page":"16866","DOI":"10.1038\/s41598-018-35376-6","volume":"8","author":"J Youn","year":"2018","unstructured":"Youn J, Lee SB, Lee HS, Yang HO, Park J, Kim JS, et al. Cerebrospinal fluid levels of autophagy-related proteins represent potentially novel biomarkers of early-stage Parkinson\u2019s disease. Sci Rep. 2018;8(1):16866.","journal-title":"Sci Rep"},{"issue":"2","key":"555_CR167","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3233\/JPD-150759","volume":"6","author":"A Boman","year":"2016","unstructured":"Boman A, Svensson S, Boxer A, Rojas JC, Seeley WW, Karydas A, et al. Distinct lysosomal network protein profiles in Parkinsonian syndrome cerebrospinal fluid. J Parkinsons Dis. 2016;6(2):307\u201315.","journal-title":"J Parkinsons Dis"},{"issue":"Pt 9","key":"555_CR168","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/brain\/awv179","volume":"138","author":"RN Alcalay","year":"2015","unstructured":"Alcalay RN, Levy OA, Waters CC, Fahn S, Ford B, Kuo SH, et al. Glucocerebrosidase activity in Parkinson\u2019s disease with and without GBA mutations. Brain. 2015;138(Pt 9):2648\u201358.","journal-title":"Brain"},{"issue":"5","key":"555_CR169","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/mds.28472","volume":"36","author":"S Lerche","year":"2021","unstructured":"Lerche S, Schulte C, Wurster I, Machetanz G, Roeben B, Zimmermann M, et al. The mutation matters: CSF profiles of GCase, sphingolipids, alpha-synuclein in PD(GBA). Mov Disord. 2021;36(5):1216\u201328.","journal-title":"Mov Disord"},{"issue":"6","key":"555_CR170","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/mds.25495","volume":"28","author":"KD van Dijk","year":"2013","unstructured":"van Dijk KD, Persichetti E, Chiasserini D, Eusebi P, Beccari T, Calabresi P, et al. Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson\u2019s disease. Mov Disord. 2013;28(6):747\u201354.","journal-title":"Mov Disord"},{"issue":"9","key":"555_CR171","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/acn3.51856","volume":"10","author":"Y Mizutani","year":"2023","unstructured":"Mizutani Y, Nawashiro K, Ohdake R, Tatebe H, Shima S, Ueda A, et al. Enzymatic properties and clinical associations of serum alpha-galactosidase A in Parkinson\u2019s disease. Ann Clin Transl Neurol. 2023;10(9):1662\u201372.","journal-title":"Ann Clin Transl Neurol"},{"issue":"10","key":"555_CR172","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/mds.27136","volume":"32","author":"L Parnetti","year":"2017","unstructured":"Parnetti L, Paciotti S, Eusebi P, Dardis A, Zampieri S, Chiasserini D, et al. Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in parkinson\u2019s disease patients. Mov Disord. 2017;32(10):1423\u201331.","journal-title":"Mov Disord"},{"issue":"1","key":"555_CR173","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1038\/s41467-023-41539-5","volume":"14","author":"Y He","year":"2023","unstructured":"He Y, Kaya I, Shariatgorji R, Lundkvist J, Wahlberg LU, Nilsson A, et al. Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents. Nat Commun. 2023;14(1):5804.","journal-title":"Nat Commun"},{"issue":"1","key":"555_CR174","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41531-024-00714-1","volume":"10","author":"M Bartl","year":"2024","unstructured":"Bartl M, Nilsson J, Dakna M, Weber S, Schade S, Xylaki M, et al. Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson\u2019s disease. NPJ Parkinsons Dis. 2024;10(1):102.","journal-title":"NPJ Parkinsons Dis"},{"key":"555_CR175","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neulet.2019.04.003","volume":"704","author":"N Papagiannakis","year":"2019","unstructured":"Papagiannakis N, Xilouri M, Koros C, Simitsi AM, Stamelou M, Maniati M, et al. Autophagy dysfunction in peripheral blood mononuclear cells of Parkinson\u2019s disease patients. Neurosci Lett. 2019;704:112\u20135.","journal-title":"Neurosci Lett"},{"key":"555_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.107151","volume":"217","author":"Y Mizutani","year":"2025","unstructured":"Mizutani Y, Nawashiro K, Ito S, Nakai T, Ohdake R, Shima S, et al. Elevated TFEB expression with limited activation in peripheral blood mononuclear cells reflects altered lysosomal enzyme dynamics in Parkinson\u2019s disease. Neurobiol Dis. 2025;217:107151.","journal-title":"Neurobiol Dis"},{"key":"555_CR177","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neurobiolaging.2017.11.006","volume":"63","author":"Y Miki","year":"2018","unstructured":"Miki Y, Shimoyama S, Kon T, Ueno T, Hayakari R, Tanji K, et al. Alteration of autophagy-related proteins in peripheral blood mononuclear cells of patients with Parkinson\u2019s disease. Neurobiol Aging. 2018;63:33\u201343.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"555_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100661","volume":"3","author":"O Karayel","year":"2022","unstructured":"Karayel O, Virreira Winter S, Padmanabhan S, Kuras YI, Vu DT, Tuncali I, et al. Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson\u2019s disease. Cell Rep Med. 2022;3(6):100661.","journal-title":"Cell Rep Med"},{"issue":"3","key":"555_CR179","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013257","volume":"13","author":"S Virreira Winter","year":"2021","unstructured":"Virreira Winter S, Karayel O, Strauss MT, Padmanabhan S, Surface M, Merchant K, et al. Urinary proteome profiling for stratifying patients with familial Parkinson\u2019s disease. EMBO Mol Med. 2021;13(3):e13257.","journal-title":"EMBO Mol Med"},{"key":"555_CR180","doi-asserted-by":"crossref","unstructured":"Xiao C, Shimizu T, Huang BT, Vu DT, Itang E, Mann M, et al. Integrated biofluid proteomics identified dynamic functional biomarkers of LRRK2-linked Parkinson\u2019s disease progression. medRxiv. 2025.","DOI":"10.64898\/2025.12.22.25342856"},{"issue":"51","key":"555_CR181","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adv1434","volume":"11","author":"EC Bogacki","year":"2025","unstructured":"Bogacki EC, Parfitt GM, Cunha A, Longmore G, Wray S, Lewis PA, et al. GPNMB is a biomarker for lysosomal dysfunction and is secreted via LRRK2-modulated lysosomal exocytosis. Sci Adv. 2025;11(51):eadv1434.","journal-title":"Sci Adv"},{"key":"555_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105844","volume":"118","author":"S Oh","year":"2025","unstructured":"Oh S, Jung J, Kim J, Jang Y, Bakker CC, Pantelyat AY, et al. Discovery and validation of biomarkers for Parkinson\u2019s disease from human cerebrospinal fluid using mass spectrometry-based proteomics analysis. EBioMedicine. 2025;118:105844.","journal-title":"EBioMedicine"},{"issue":"8","key":"555_CR183","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S1474-4422(25)00194-2","volume":"24","author":"J Agin-Liebes","year":"2025","unstructured":"Agin-Liebes J, Lodge A, Reddy H, Vacchi E, Usseglio J, Honig LS, et al. alpha-synuclein biomarker assays: bridging research and patient care. Lancet Neurol. 2025;24(8):681\u201397.","journal-title":"Lancet Neurol"},{"issue":"1","key":"555_CR184","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-017-0154-3","volume":"12","author":"TE Moors","year":"2017","unstructured":"Moors TE, Hoozemans JJ, Ingrassia A, Beccari T, Parnetti L, Chartier-Harlin MC, et al. Therapeutic potential of autophagy-enhancing agents in Parkinson\u2019s disease. Mol Neurodegener. 2017;12(1):11.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"555_CR185","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/jamaneurol.2019.4611","volume":"77","author":"S Mullin","year":"2020","unstructured":"Mullin S, Smith L, Lee K, D\u2019Souza G, Woodgate P, Elflein J, et al. Ambroxol for the treatment of patients with Parkinson disease with and without glucocerebrosidase gene mutations: a nonrandomized, noncontrolled trial. JAMA Neurol. 2020;77(4):427\u201334.","journal-title":"JAMA Neurol"},{"issue":"1","key":"555_CR186","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1186\/s12967-025-06354-0","volume":"23","author":"M Karami","year":"2025","unstructured":"Karami M, Sanaye PM, Ghorbani A, Amirian R, Goleij P, Babamohamadi M, et al. Recent advances in targeting LRRK2 for Parkinson\u2019s disease treatment. J Transl Med. 2025;23(1):754.","journal-title":"J Transl Med"},{"issue":"8","key":"555_CR187","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1172\/JCI85456","volume":"126","author":"S Brahmachari","year":"2016","unstructured":"Brahmachari S, Ge P, Lee SH, Kim D, Karuppagounder SS, Kumar M, et al. Activation of tyrosine kinase c-Abl contributes to alpha-synuclein-induced neurodegeneration. J Clin Invest. 2016;126(8):2970\u201388.","journal-title":"J Clin Invest"},{"issue":"38","key":"555_CR188","doi-asserted-by":"publisher","first-page":"16691","DOI":"10.1073\/pnas.1006083107","volume":"107","author":"HS Ko","year":"2010","unstructured":"Ko HS, Lee Y, Shin JH, Karuppagounder SS, Gadad BS, Koleske AJ, et al. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin\u2019s ubiquitination and protective function. Proc Natl Acad Sci USA. 2010;107(38):16691\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"555_CR189","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mds.28858","volume":"37","author":"MH Werner","year":"2022","unstructured":"Werner MH, Olanow CW. Parkinson\u2019s disease modification through Abl kinase inhibition: an opportunity. Mov Disord. 2022;37(1):6\u201315.","journal-title":"Mov Disord"},{"issue":"3","key":"555_CR190","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/jamaneurol.2020.4725","volume":"78","author":"T Simuni","year":"2021","unstructured":"Simuni T, Fiske B, Merchant K, Coffey CS, Klingner E, Caspell-Garcia C, et al. Efficacy of nilotinib in patients with moderately advanced Parkinson Disease: a randomized clinical trial. JAMA Neurol. 2021;78(3):312\u201320.","journal-title":"JAMA Neurol"},{"issue":"5","key":"555_CR191","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa2203395","volume":"387","author":"AE Lang","year":"2022","unstructured":"Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, et al. Trial of cinpanemab in early Parkinson\u2019s disease. N Engl J Med. 2022;387(5):408\u201320.","journal-title":"N Engl J Med"},{"issue":"4","key":"555_CR192","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","volume":"30","author":"G Pagano","year":"2024","unstructured":"Pagano G, Taylor KI, Anzures Cabrera J, Simuni T, Marek K, Postuma RB, et al. Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson\u2019s disease. Nat Med. 2024;30(4):1096\u2013103.","journal-title":"Nat Med"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00555-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-026-00555-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00555-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:03:27Z","timestamp":1778141007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40035-026-00555-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":192,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["555"],"URL":"https:\/\/doi.org\/10.1186\/s40035-026-00555-3","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}